Valproic acid preserves motoneurons following contusion in organotypic spinal cord slice culture

References

• Silva NA, Sousa N, Reis RL, Salgado AJ. From basics to clinical: a comprehensive review on spinal cord injury. Prog Neurobiol 2014;114:25–57. doi: 10.1016/j.pneurobio.2013.11.002
   PubMed Web of Science ®Google Scholar
• Sahni V, Kessler JA. Stem cell therapies for spinal cord injury. Nat Rev Neurol 2010;6(7):363–72. doi: 10.1038/nrneurol.2010.73
   PubMed Web of Science ®Google Scholar
• Thuret S, Moon LD, Gage FH. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci 2006;7(8):628–43. doi: 10.1038/nrn1955
   PubMed Web of Science ®Google Scholar
• Chateauvieux S, Morceau F, Dicato M, Diederich M. Molecular and therapeutic potential and toxicity of valproic acid. J Biomed Biotechnol 2010;2010. doi: 10.1155/2010/479364
   PubMedGoogle Scholar
• Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT. Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 2009;32(11):591–601. doi: 10.1016/j.tins.2009.06.002
   PubMed Web of Science ®Google Scholar
• Cincarova L, Zdrahal Z, Fajkus J. New perspectives of valproic acid in clinical practice. Expert Opin Investig Drugs 2013;22(12):1535–47. doi: 10.1517/13543784.2013.853037
   PubMed Web of Science ®Google Scholar
• Nalivaeva NN, Belyaev ND, Turner AJ. Sodium valproate: an old drug with new roles. Trends Pharmacol Sci 2009;30(10):509–14. doi: 10.1016/j.tips.2009.07.002
   PubMed Web of Science ®Google Scholar
• Hao HH, Wang L, Guo ZJ, Bai L, Zhang RP, Shuang WB, et al. Valproic acid reduces autophagy and promotes functional recovery after spinal cord injury in rats. Neurosci Bull 2013;29(4):484–92. doi: 10.1007/s12264-013-1355-6
   PubMed Web of Science ®Google Scholar
• Penas C, Verdu E, Asensio-Pinilla E, Guzman-Lenis MS, Herrando-Grabulosa M, Navarro X, et al. Valproate reduces CHOP levels and preserves oligodendrocytes and axons after spinal cord injury. Neuroscience 2011;178:33–44. doi: 10.1016/j.neuroscience.2011.01.012
   PubMed Web of Science ®Google Scholar
• Sugai F, Yamamoto Y, Miyaguchi K, Zhou Z, Sumi H, Hamasaki T, et al. Benefit of valproic acid in suppressing disease progression of ALS model mice. Eur J Neurosci 2004;20(11):3179–83. doi: 10.1111/j.1460-9568.2004.03765.x
   PubMed Web of Science ®Google Scholar
• Stoppini L, Buchs PA, Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 1991;37(2):173–82. doi: 10.1016/0165-0270(91)90128-M
   PubMed Web of Science ®Google Scholar
• Krassioukov AV, Ackery A, Schwartz G, Adamchik Y, Liu Y, Fehlings MG. An in vitro model of neurotrauma in organotypic spinal cord cultures from adult mice. Brain Res Protoc 2002;10(2):60–8. doi: 10.1016/S1385-299X(02)00180-0
   PubMedGoogle Scholar
• Pandamooz S, Nabiuni M, Miyan J, Ahmadiani A, Dargahi L. Organotypic spinal cord culture: a proper platform for the functional screening. Mol Neurobiol 2015;1–16.
   Web of Science ®Google Scholar
• Hurlbert RJ, Hadley MN, Walters BC, Aarabi B, Dhall SS, Gelb DE, et al. Pharmacological therapy for acute spinal cord injury. Neurosurgery 2015;76:S71–S83. doi: 10.1227/01.neu.0000462080.04196.f7
   PubMedGoogle Scholar
• Wilems TS, Pardieck J, Iyer N, Sakiyama-Elbert SE. Combination therapy of stem cell derived neural progenitors and drug delivery of anti-inhibitory molecules for spinal cord injury. Acta Biomater 2015;28:23–32. doi: 10.1016/j.actbio.2015.09.018
   PubMed Web of Science ®Google Scholar
• Johnson PJ, Tatara A, Shiu A, Sakiyama-Elbert SE. Controlled release of neurotrophin-3 and platelet derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant 2010;19(1):89. doi: 10.3727/096368909X477273
   PubMed Web of Science ®Google Scholar
• Mazzone GL, Mladinic M, Nistri A. Excitotoxic cell death induces delayed proliferation of endogenous neuroprogenitor cells in organotypic slice cultures of the rat spinal cord. Cell Death Dis 2013;4(10):e902. doi: 10.1038/cddis.2013.431
   Google Scholar
• Lu W-H, Wang C-Y, Chen P-S, Wang J-W, Chuang D-M, Yang C-S, et al. Valproic acid attenuates microgliosis in injured spinal cord and purinergic P2X4 receptor expression in activated microglia. J Neurosci Res 2013;91(5):694–705. doi: 10.1002/jnr.23200
   PubMed Web of Science ®Google Scholar
• Lv L, Sun Y, Han X, Xu Cc, Tang YP, Dong Q. Valproic acid improves outcome after rodent spinal cord injury: potential roles of histone deacetylase inhibition. Brain Res 2011;1396:60–8. doi: 10.1016/j.brainres.2011.03.040
   PubMed Web of Science ®Google Scholar
• Lv L, Han X, Sun Y, Wang X, Dong Q. Valproic acid improves locomotion in vivo after SCI and axonal growth of neurons in vitro. Exp Neurol 2012;233(2):783–90. doi: 10.1016/j.expneurol.2011.11.042
   PubMed Web of Science ®Google Scholar
• Abematsu M, Tsujimura K, Yamano M, Saito M, Kohno K, Kohyama J, et al. Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury. J Clin Invest 2010;120(9):3255–66. doi: 10.1172/JCI42957
   PubMed Web of Science ®Google Scholar
• Su Z, Niu W, Liu ML, Zou Y, Zhang CL. In vivo conversion of astrocytes to neurons in the injured adult spinal cord. Nat Commun 2014;5(3338).
   Google Scholar
• Penas C, Guzman M-S, Verdu E, Fores J, Navarro X, Casas C. Spinal cord injury induces endoplasmic reticulum stress with different cell-type dependent response. J Neurochem 2007;102(4):1242–55. doi: 10.1111/j.1471-4159.2007.04671.x
   PubMed Web of Science ®Google Scholar
• Ronaghi M, Erceg S, MorenoGÇÉManzano V, Stojkovic M. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Stem Cells 2010;28(1):93–9.
   PubMed Web of Science ®Google Scholar
• Chu T, Zhou H, Lu L, Kong X, Wang T, Pan B, et al. Valproic acid-mediated neuroprotection and neurogenesis after spinal cord injury: from mechanism to clinical potential. Regen Med 2015;10(2):193–209. doi: 10.2217/rme.14.86
   PubMed Web of Science ®Google Scholar
• Lee JY, Maeng S, Kang SR, Choi HY, Oh TH, Ju BG, et al. Valproic acid protects motor neuron death by inhibiting oxidative stress and endoplasmic reticulum stress-mediated cytochrome C release after spinal cord injury. J Neurotrauma 2014;31(6):582–94. doi: 10.1089/neu.2013.3146
   PubMed Web of Science ®Google Scholar
• Monti B, Polazzi E, Contestabile A. Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol 2009;2(1):95–109. doi: 10.2174/1874467210902010095
   PubMedGoogle Scholar
• Ximenes JCM, Verde ECL, da Graca Naffah-Mazzacoratti M, de Barros Viana GS. Valproic acid, a drug with multiple molecular targets related to its potential neuroprotective action. Neurosci Med 2012;3(1):107. doi: 10.4236/nm.2012.31016
   Google Scholar